Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Researchers Uncover Allergy-cancer Connection … >
Researchers Uncover Allergy-cancer Connection

Published: March 19, 2014.
By Virginia Commonwealth University
http://www.vcu.edu

While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.

Recently published in the Journal of Leukocyte Biology, the study was led by Daniel H. Conrad, Ph.D., member of the Cancer Cell Signaling research program at Massey and professor of microbiology and immunology at the VCU School of Medicine, with substantial contributions from Ph.D. students and co-first authors Rebecca K. Martin and Sheinei J. Saleem. The study demonstrated that histamine, a component of the immune system that responds to allergens and foreign pathogens and is also linked to inflammation, plays a role in protecting tumors from the immune system. By blocking the production of histamine in animal models, the researchers were able to interrupt a process that promotes melanoma growth.

"This research is very exciting as it draws a connection between two diseases that aren't commonly linked: allergy and cancer," says Conrad. "However, it's important to realize that this connection is very novel and further research is needed before we know if antihistamines can be used effectively in cancer therapies."

Histamine is produced by mast cells, which are especially numerous in the nose, mouth and blood vessels to help defend against pathogens and aid in wound healing. The researchers found that histamine induces the activation, survival and proliferation of myeloid derived suppressor cells (MDSCs), which help promote tumor growth by suppressing the immune system. They also discovered that MDSCs tend to migrate toward mast cells, which help traffic the MDSCs to sites of inflammation such as the liver and tumors. The cycle continues as histamine released by mast cells further promotes the survival and proliferation of MDSCs. This occurs in two subpopulations of MDSCs, but most dramatically in the monocytic subpopulation. Through their experiments, the researchers showed that monocytic MDSCs can be decreased by over-the-counter antihistamines such as cetirizine (Zyrtec) and cimetidine (Tagamet).

In addition, the researchers found that patients experiencing allergic symptoms have more MDSCs circulating in their bloodstream than non-allergic patients.

"MDSCs have generated a great deal of interest in recent years because they limit the effects of the immune response against cancer," says study collaborator Harry D. Bear, M.D., Ph.D., member of the Developmental Therapeutics research program at Massey, professor and chair of the Division of Surgical Oncology at the VCU School of Medicine and director of the Breast Health Center at VCU Health System. "Now that we have shown that antihistamines can interfere with the production of MDSCs, we are hopeful that we may be able to use them to restore the immune system's ability to fight off tumors."

Previously, the research team found that mast cells were essential for MDSC activity. Their next step is to further dissect the mechanism of the mast cell and MDSC interaction and the involvement of other mast cell mediators, like histamine, in MDSC function.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Cancer 
8/13/14 

Injected Bacteria Shrink Tumors in Rats, Dogs And Humans
By Johns Hopkins Medicine
Cancer 
8/13/14 
Bacterial Biosurgery Shows Promise for Reducing the Size of Inoperable Tumors
By Stowers Institute for Medical Research
Kansas City, MO. — Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These troublesome spots lack the blood and oxygen needed for traditional therapies …
Treatment 
4/10/13 
Ludwig Presents Advancements in Immunotherapy And Epigenetics at the American Association for Cancer Research Annual Meeting
By Ludwig Institute for Cancer Research
April 10, 2013, New York, NY – A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American …
Tnbc 
10/1/12 
A Form of Small Pox Virus Shows Potential for Treating Triple-negative Breast Cancer
By American College of Surgeons
CHICAGO—Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City have shown that a new vaccinia virus, acting as both an oncolytic and anti-angiogenic agent, can enter and …
Rudin 
11/10/11 
Combination Epigenetic Therapy Clinical Trial Results
By Johns Hopkins Medical Institutions
A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns …
Sequencing 
4/2/12 
TGen Presents Triple-negative Breast Cancer Study Supported by Life Technologies
By The Translational Genomics Research Institute
Because cases of Triple-Negative Breast Cancer (TNBC) are so genetically different, whole-genome sequencing is needed to detect the subtle molecular differences that might point to specific treatments for individual …
Center 
6/2/14 
Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells
By University of Colorado Denver
At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), …
Patient 
9/10/13 
Study: Redefining the Criteria for ALK Positive Lung Cancer
By University of Colorado Denver
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss …
Skin 
10/9/14 
★★★ 

Unusual Skin Cancer Linked to Chronic Allergy from Metal Orthopedic Implant
By Washington University School of Medicine
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition